Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 226,396 |
|
|||||
| News | - | ||||||
| Day High | 15.97 | Low High |
|||||
| Day Low | 15.31 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Tourmaline Bio Inc | TRML | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.25 | 1.61% | 15.78 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 15.53 | 15.31 | 15.97 | 15.78 | 15.53 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,448 | 226,396 | US$ 15.70 | US$ 3,554,023 | - | 9.18 - 48.31 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:15:48 | 1 | US$ 15.81 | USD |
Tourmaline Bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 320.1M | 20.34M | - | 0 | -42.12M | -2.07 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Tourmaline Bio News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TRML Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 15.50 | 16.58 | 15.12 | 15.79 | 287,881 | 0.28 | 1.81% |
| 1 Month | 23.09 | 23.18 | 14.70 | 16.51 | 457,383 | -7.31 | -31.66% |
| 3 Months | 36.21 | 48.31 | 14.70 | 25.89 | 448,630 | -20.43 | -56.42% |
| 6 Months | 15.22 | 48.31 | 13.81 | 26.76 | 300,090 | 0.56 | 3.68% |
| 1 Year | 10.32 | 48.31 | 9.18 | 26.37 | 282,044 | 5.46 | 52.91% |
| 3 Years | 10.32 | 48.31 | 9.18 | 26.37 | 282,044 | 5.46 | 52.91% |
| 5 Years | 10.32 | 48.31 | 9.18 | 26.37 | 282,044 | 5.46 | 52.91% |
Tourmaline Bio Description
| Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders. |
